Suchergebnisse - "Vincenzi, Bruno"

PubPharm (17)

1

How do skeletal morbidity rate and special toxicities affect 12-week versus 4-week schedule zoledronic acid efficacy? A systematic review and a meta-analysis of randomized trials

enthalten in: Critical reviews in oncology/hematology | 2019

von Santini, D. | Galvano, A. | Pantano, F. | +11

2

Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting

enthalten in: Oncology | 2013

von Santini, D. | Zoccoli, A. | Gregorj, C. | +13

3

Zoledronic acid in the treatment of bone metastases by hepatocellular carcinoma : a case series

enthalten in: Cancer chemotherapy and pharmacology | 2010

von Montella, L. | Addeo, R. | Palmieri, G. | +13

4

Cyr61 downmodulation potentiates the anticancer effects of zoledronic acid in androgen-independent prostate cancer cells

enthalten in: International journal of cancer | 2009

von Marra, M. | Santini, D. | Meo, G. | +11

5

Medical oncology : zoledronic acid prevents bone loss in early-stage breast cancer

enthalten in: Nature reviews. Clinical oncology | 2009

von Bertoldo, F. | Tonini, G. | Vincenzi, B. | +1

6

In vivo effects of zoledronic acid on peripheral gammadelta T lymphocytes in early breast cancer patients

enthalten in: Cancer immunology, immunotherapy : CII | 2009

von Santini, D. | Martini, F. | Fratto, M. | +9

7

Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis : a single-institution report

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2008

von Addeo, R. | Nocera, V. | Faiola, V. | +11

8

A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid

enthalten in: Skeletal radiology | 2007

von Quattrocchi, C. | Santini, D. | Dell'aia, P. | +6

9

Repeated intermittent low-dose therapy with zoledronic acid induces an early, sustained, and long-lasting decrease of peripheral vascular endothelial growth factor levels in cancer patients

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2007

von Santini, D. | Vincenzi, B. | Galluzzo, S. | +9

CommentIn: Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6850; author reply 6850-1. - PMID 18006788

10

Zoledronic acid in the management of metastatic bone disease

enthalten in: Expert opinion on biological therapy | 2006

von Santini, D. | Fratto, M. | Vincenzi, B. | +2